Guidant announces market release of VENTAK AV Defibrillation system in Europe.INDIANAPOLIS--(HealthWire)--Nov. 8, 1996--Guidant Corporation (NYSE NYSE See: New York Stock Exchange and PSE PSE 1. pale soft exudative pork. 2. portosystemic encephalopathy. :GDT), a worldwide leader in implantable defibrillation Defibrillation Definition Defibrillation is a process in which an electronic device sends an electric shock to the heart to stop an extremely rapid, irregular heartbeat, and restore the normal heart rhythm. systems, today announced the market release of the VENTAK(R) AV AICD AICD activation-induced cell death; automatic implantable cardioverter-defibrillator. (TM) Automatic Implantable Cardioverter Defibulator system in Europe. This new system incorporates Guidant's sophisticated dual-chamber pacemaker therapy and proven defibrillation capabilities. Manufactured by CPI, part of Guidant's Cardiac Rhythm Management Cardiac rhythm management is a field of treatment in cardiology. The purpose is managing cardiac rhythm disorders. Usually it involves artificial pacemakers and/or implantable cardioverter-defibrillator therapy as well as antiarrhythmia drugs. group (CRM), the VENTAK AV sets a new standard for treating patients with life-threatening rapid heart arrhythmias. The system's unique ATRIAL VIEW(TM) collects information from the heart's atrium (upper chamber) for use in the device's arrhythmia treatment algorithms. "We are excited about the expanded treatment options that the VENTAK AV system can provide to patients at risk for life- threatening arrhythmias," noted Jay Graf, president of CRM. "The VENTAK AV system is the world's first integration of sophisticated dual-chamber pacing therapy and advanced defibrillation therapy. Our implants in Europe, which began September 2 following CE mark approval, have indicated a high degree of interest from physicians on the capabilities of this new system," Graf added. "Physicians are especially interested in the new ATRIAL VIEW, which provides more information to help distinguish between fast atrial arrhythmias that are not life-threatening and fast ventricular arrhythmias that are," Graf added. "This capability, along with dual-chamber pacing therapy that includes mode switching, provides therapy for treating fast and slow heart arrhythmias in one device. We believe that this product will become the system of choice for physicians treating patients with a unique combination of atrial and ventricular heart arrhythmias." The VENTAK AV device is designed for implantation in the patient's shoulder (pectoral pectoral /pec·to·ral/ (pek´ter-il) thoracic. pec·to·ral adj. 1. Relating to or situated in the breast or chest. 2. ) area, which can greatly reduce the time and costs associated with the implant procedure and enhance patient comfort. The VENTAK AV system includes comprehensive therapy and diagnostics, 16 minutes of annotated, diagnostic-quality stored electrograms that document activity in both the atrium and ventricle ventricle /ven·tri·cle/ (ven´tri-k'l) a small cavity or chamber, as in the brain or heart.ventric´ular ventricle of Arantius the rhomboid fossa, especially its lower end. , and Guidant's proven biphasic bi·pha·sic adj. Having two distinct phases: a biphasic waveform; a biphasic response to a stimulus. energy delivery waveform. The VENTAK AV system also incorporates CPI's patented ENDOTAK(R) lead and TRIAD(TM) three-electrode energy defibrillation system. Designed to reduce the amount of energy needed for defibrillation by as much as 15 percent, the TRIAD system uses the VENTAK pulse generator as one electrode of the system in combination with the electrodes on the ENDOTAK lead to provide increased electrode surface area and reduced system resistance, two factors that are critical to efficient energy delivery. A leader in the medical device industry, Guidant provides innovative, cost-effective products and services to the global cardiology and minimally invasive surgery minimally invasive surgery Laparoscopic surgery, see there. See Laparoscopic cholecystectomy. marketplaces. CONTACT: Guidant Corporation, Indianapolis Carol Lindahl, 612/582-4461 Todd McKinney, 317/971-2094 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion